Figure 2
SHELX output. (a) SHELXD substructure-determination output for DgkA for 1000 trials. (b) SHELXE output for DgkA after ten cycles of auto-tracing. (c) SHELXD substructure-determination output for Cas9 for 1000 trials. (d) SHELXE output for Cas9 after three cycles of auto-tracing. (e) SHELXD substructure determination for T2R-TTL with 1000 trials. (f) Three cycles of chain tracing with phasing and density modification in SHELXE for T2R-TTL. |